Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis
Background/objective The aim of this study was to evaluate relative performance of composite measures in psoriatic arthritis and assess the impact of structural damage and functional disability on outcomes during ixekizumab treatment.Methods Data from SPIRIT-P1 and SPIRIT-P2 were analysed to evaluat...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-11-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/8/2/e002457.full |